Hrt Financial LP Apellis Pharmaceuticals, Inc. Transaction History
Hrt Financial LP
- $18.1 Billion
- Q3 2024
A detailed history of Hrt Financial LP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 56,423 shares of APLS stock, worth $1.94 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
56,423Holding current value
$1.94 Million% of portfolio
0.01%Shares
8 transactions
Others Institutions Holding APLS
# of Institutions
309Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$535 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$409 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$382 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$337 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$199 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.78B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...